Drug interaction potential of high-dose rifampicin in patients with pulmonary tuberculosis.

Saved in:
Bibliographic Details
Title: Drug interaction potential of high-dose rifampicin in patients with pulmonary tuberculosis.
Authors: Stemkens R; Department of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Center , Nijmegen, The Netherlands., Jager Vd; TASK , Cape Town, South Africa., Dawson R; Division of Pulmonology and Department of Medicine, University of Cape Town and University of Cape Town Lung Institute , Cape Town, South Africa., Diacon AH; TASK , Cape Town, South Africa., Narunsky K; Division of Pulmonology and Department of Medicine, University of Cape Town and University of Cape Town Lung Institute , Cape Town, South Africa., Padayachee SD; Division of Pulmonology and Department of Medicine, University of Cape Town and University of Cape Town Lung Institute , Cape Town, South Africa., Boeree MJ; Department of Pulmonary Diseases, Research Institute for Medical Innovation, Radboud University Medical Center , Nijmegen, The Netherlands., van Beek SW; Department of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Center , Nijmegen, The Netherlands., Colbers A; Department of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Center , Nijmegen, The Netherlands., Coenen MJH; Department of Clinical Chemistry, Erasmus University Medical Center , Rotterdam, The Netherlands., Svensson EM; Department of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Center , Nijmegen, The Netherlands.; Department of Pharmacy, Uppsala University , Uppsala, Sweden., Fuhr U; 7 Clinical Pharmacology, Department I of Pharmacology, Center for Pharmacology, Faculty of Medicine and University Hospital Cologne, University of Cologne , Cologne, Germany., Phillips PPJ; UCSF Center for Tuberculosis, University of California , San Francisco, California, USA., Te Brake LHM; Department of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Center , Nijmegen, The Netherlands., Aarnoutse RE; Department of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Center , Nijmegen, The Netherlands.
Corporate Authors: PanACEA consortium
Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2023 Oct 18; Vol. 67 (10), pp. e0068323. Date of Electronic Publication: 2023 Sep 28.
Publication Type: Journal Article
Journal Info: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1098-6596
DOI:10.1128/aac.00683-23